Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Retraction for Gelband et al., Hypertension 33 (1) 360-365.
Hypertension. 2004;43:292
Published online before print January 12, 2004, doi: 10.1161/01.HYP.0000115602.94075.bb
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/2/292    most recent
01.HYP.0000115602.94075.bbv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

(Hypertension. 2004;43:292.)
© 2004 American Heart Association, Inc.

Retraction


An extract of the first 100% of the full text is provided, because this article has no abstract.
 

Gelband CH, Reaves PY, Evans J, Wang H, Katovich MJ, Raizada MK. Angiotensin II Type 1 Receptor Antisense Gene Therapy Prevents Altered Renal Vascular Calcium Homeostasis in Hypertension. Hypertension. 1999;33:360–465.

Due to lack of supporting data, Figure 3 will be retracted from the following article at Dr Craig H. Gelband’s request.

This is in accordance with the decision of the Office of Research Integrity (ORI) and the Assistant Secretary for Health against Dr Gelband for scientific misconduct. The decision is listed in the Federal Register: November 10, 2003 (Volume 68, Number 217).